Human respiratory syncytial virus
GPTKB entity
Statements (65)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:affects |
elderly
infants |
gptkbp:cause |
respiratory infections
|
gptkbp:clinical_trial |
fatigue
ongoing sore throat nasal congestion loss of appetite upper respiratory tract infection lower respiratory tract infection |
gptkbp:community_health |
high hospitalization rates
|
gptkbp:complications |
gptkb:pneumonia
hospitalization bronchiolitis |
gptkbp:condition |
gptkb:asthma
gptkb:cystic_fibrosis |
gptkbp:diagnosis |
serology
PCR test rapid antigen test nasal swab |
gptkbp:epidemiology |
seasonal outbreaks
|
gptkbp:family |
gptkb:Paramyxoviridae
|
gptkbp:genus |
gptkb:Pneumovirus
|
gptkbp:grooming_needs |
up to 3 weeks
|
https://www.w3.org/2000/01/rdf-schema#label |
Human respiratory syncytial virus
|
gptkbp:immune_response |
Ig G antibodies
Ig A antibodies |
gptkbp:is_monitored_by |
public health monitoring
|
gptkbp:is_recognized_as |
gptkb:1956
|
gptkbp:is_vulnerable_to |
no approved vaccine
|
gptkbp:outbreak_management |
gptkb:quarantine_measures
contact tracing |
gptkbp:prevalence |
common worldwide
|
gptkbp:prevention |
hand hygiene
avoiding close contact |
gptkbp:provides_guidance_on |
CDC recommendations
WHO guidelines |
gptkbp:public_awareness |
gptkb:educational_campaigns
healthcare provider training |
gptkbp:research_focus |
vaccine development
antiviral therapies |
gptkbp:risk_factor |
premature birth
chronic lung disease congenital heart disease |
gptkbp:risk_management |
young children
immunocompromised individuals |
gptkbp:seasonal_activities |
winter months
|
gptkbp:symptoms |
cough
fever difficulty breathing wheezing |
gptkbp:transmission |
person-to-person
aerosol droplets fomites |
gptkbp:treatment |
gptkb:ribavirin
supportive care oxygen therapy palivizumab |
gptkbp:type_of |
gptkb:A
B |
gptkbp:viral_characteristics |
single-stranded RNA
enveloped virus |
gptkbp:bfsParent |
gptkb:Pneumovirus
|
gptkbp:bfsLayer |
7
|